Taiho Oncology, Inc.
A strategic leadership role overseeing the design, execution, and reporting of Phase 1 through 3 clinical oncology trials. This position leverages advanced medical and scientific expertise to support regulatory submissions, protocol development, and safety data review while ensuring compliance and collaborating with cross-functional teams to advance cancer therapies.
Headquarters
Princeton, New Jersey, United States
Company Size
201-500 employees
Founded
2002
Taiho Oncology, Inc. is a U.S.-based biopharmaceutical company focused on discovering, developing, and commercializing innovative cancer treatments. The company works across oncology research, clinical development, and patient support to bring therapies to people living with cancer. Taiho Oncology operates in the biotechnology and pharmaceutical industry as part of the broader Taiho Pharmaceutical Group.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Taiho Oncology, Inc..
33% above the average for this role